(Q31115845)

English

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

0 references

immunization safety

1 reference

based on heuristic

inferred from title

acute disseminated encephalomyelitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Katrin Susanne Kohl

2

object named as

Katrin S Kohl

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1

object named as

James J Sejvar

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Najwa Khuri-Bulos

9

object named as

Najwa Khuri-Bulos

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

author name string

Roman Bilynsky

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Dean Blumberg

4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Therese Cvetkovich

5

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Jochem Galama

6

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Jane Gidudu

7

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Lakshmi Katikaneni

8

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

James Oleske

10

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Terhi Tapiainen

11

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Max Wiznitzer

12

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Brighton Collaboration Encephalitis Working Group

13

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

language of work or name

0 references

publication date

11 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

number of pages

22

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

5771-5792

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

STUDIES ON VIRAL ENCEPHALITIS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

The incidence and aetiology of central nervous system infections in Helsinki in 1980

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Epidemiology of encephalitis in children. A prospective multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Etiology of acute encephalitis in childhood in Slovenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Disorders that mimic central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Burden of encephalitis-associated hospitalizations in the United States, 1988-1997.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Surveillance for Unexplained Deaths and Critical Illnesses Due to Possibly Infectious Causes, United States, 1995-1998

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Neurological complications to vaccination against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Poliomyelitis in the USA: virtual elimination of disease caused by wild virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute demyelinating disease. Classification and non-invasive diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis associated with Pasteurella multocida meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Chlamydia pneumoniae-associated ADEM.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

The development of standardized case definitions and guidelines for adverse events following immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute viral encephalitis: its diagnosis and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

The cytology of the normal cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Normal Laboratory Values of CSF During Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Cerebrospinal fluid values in the term neonate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Effect on the white cell count of contaminating cerebrospinal fluid with blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Lack of validity of standard corrections for white blood cell counts of blood-contaminated cerebrospinal fluid in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Determination of leukocytosis in traumatic spinal tap specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Distinguishing cerebrospinal fluid abnormalities in children with bacterial meningitis and traumatic lumbar puncture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Postictal cerebrospinal fluid abnormalities in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

PMNs in normal spinal fluid examined by the cytocentrifuge technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute Disseminated Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis: MR imaging features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Pediatric coma scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Assessment of coma and impaired consciousness. A practical scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.060

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.04.060

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31115845&oldid=1945991471"